These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6124727)

  • 1. Progress in laboratory control of oral anticoagulants.
    Loeliger EA; Lewis SM
    Lancet; 1982 Aug; 2(8293):318-20. PubMed ID: 6124727
    [No Abstract]   [Full Text] [Related]  

  • 2. Standardization of anticoagulant control.
    Poller L
    Ric Clin Lab; 1978; 8(4):237-47. PubMed ID: 734318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [External quality control and standardization of prothrombin time determination for the monitoring of oral anticoagulant treatment in the Netherlands].
    van Duuk-Wierda CA; Loeliger EA; Roos J
    Ned Tijdschr Geneeskd; 1980 Jan; 124(4):103-7. PubMed ID: 7374832
    [No Abstract]   [Full Text] [Related]  

  • 4. ICSH/ICTH recommendations for reporting prothrombin time in oral anticoagulant control.
    Loeliger EA
    Acta Haematol; 1984; 72(6):405-7. PubMed ID: 6442525
    [No Abstract]   [Full Text] [Related]  

  • 5. International sensitivity index calibration of the near-patient testing prothrombin time monitor, ProTime.
    Tripodi A; Chantarangkul V; Bressi C; Mannucci PM
    Am J Clin Pathol; 2003 Feb; 119(2):241-5. PubMed ID: 12579994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laboratory control, optimal therapeutic ranges and therapeutic quality control in oral anticoagulation.
    Loeliger EA
    Acta Haematol; 1985; 74(3):125-31. PubMed ID: 3938155
    [No Abstract]   [Full Text] [Related]  

  • 7. Oral anticoagulant monitoring by laboratory or near-patient testing: what a clinician should be aware of.
    Tripodi A; Breukink-Engbers WG; van den Besselaar AM
    Semin Vasc Med; 2003 Aug; 3(3):243-54. PubMed ID: 15199457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral anticoagulant therapy and its control: an international survey.
    Lam-Po-Tang PR; Poller L
    Thromb Diath Haemorrh; 1975 Nov; 34(2):419-25. PubMed ID: 1198405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Questions and answers on prothrombin time standardisation in oral anticoagulant control.
    Loeliger EA; Poller L; Samama M; Thomson JM; Van den Besselaar AM; Vermylen J; Verstraete M
    Thromb Haemost; 1985 Aug; 54(2):515-7. PubMed ID: 4082086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Control of oral anticoagulation. Current concepts].
    Aguilar CA; Hurtado Monroy R; Gaspar Hernández J
    Rev Invest Clin; 1989; 41(4):371-4. PubMed ID: 2698502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ICSH/ICTH recommendations for reporting prothrombin time in oral anticoagulant control.
    Clin Chim Acta; 1985 Mar; 146(2-3):229H-233H. PubMed ID: 3987050
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of lyophilized calibration plasmas and control blood for international normalized ratio calculation in external quality assessment of the prothrombin time.
    van den Besselaar AM
    Am J Clin Pathol; 1994 Jul; 102(1):123-7. PubMed ID: 8037158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress in the control of oral anticoagulation.
    Loeliger EA
    Thromb Diath Haemorrh; 1972 Aug; 28(1):109-19. PubMed ID: 5074987
    [No Abstract]   [Full Text] [Related]  

  • 14. ICSH/ICTH recommendations for reporting prothrombin time in oral anticoagulant control. International Committee for Standardization in Haematology & International Committee on Thrombosis and Haemostasis.
    Scand J Clin Lab Invest; 1985 Nov; 45(7):669-70. PubMed ID: 4070965
    [No Abstract]   [Full Text] [Related]  

  • 15. Thromboplastin and oral anticoagulant control.
    Lewis SM
    Br J Haematol; 1987 May; 66(1):1-4. PubMed ID: 3593643
    [No Abstract]   [Full Text] [Related]  

  • 16. Oral anticoagulant therapy control: evidence that INR expression improves the inter-laboratory comparability of results--the Bologna oral anticoagulant control exercise.
    Palareti G; Coccheri S; Poggi M; Bonetti M; Cervi V; Mazzuca A; Savoia M; Veri L; Fiori F; Gaspari G
    Thromb Haemost; 1987 Oct; 58(3):905-10. PubMed ID: 3433253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reliability and clinical impact of the normalization of the prothrombin times in oral anticoagulant control.
    Loeliger EA; van den Besselaar AM; Lewis SM
    Thromb Haemost; 1985 Feb; 53(1):148-54. PubMed ID: 3992514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prothrombin time reporting and the International Normalized Ratio system. Improvements are needed.
    Swaim WR
    Am J Clin Pathol; 1993 Jun; 99(6):653-5. PubMed ID: 8322697
    [No Abstract]   [Full Text] [Related]  

  • 19. [Quality control of ISI/INR system in oral anticoagulant therapy].
    Kazama M
    Rinsho Ketsueki; 1990 Jun; 31(6):769-75. PubMed ID: 2214167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gauging the accuracy of laboratory testing from Medicare data.
    Seeger B
    JAMA; 1993 Jun; 269(23):2984-5; author reply 2985-6. PubMed ID: 8501835
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.